REPORT ID 2718

United States Alpha Synuclein Market Report 2017

Publish Date
11-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the United States Alpha Synuclein market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Alpha Synuclein in these regions, from 2012 to 2022 (forecast).

United States Alpha Synuclein market competition by top manufacturers/players, with Alpha Synuclein sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AC Immune SA
    AFFiRiS AG
    BioArctic AB
    Biogen Inc
    Evotec AG
    Genmab A/S
    H. Lundbeck A/S
    ICB International Inc
    MedImmune LLC
    Neuropore Therapies Inc
    nLife Therapeutics SL
    Prothena Corp Plc
    QR Pharma Inc
    reMYND NV

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    AV-1950R
    AV-1947D
    BAN-0805
    BIIB-054
    DPC-003
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Multiple System Atrophy
    Neurodegenerateive Disease
    Lewy Body Dementia
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Alpha Synuclein Market Report 2017
1 Alpha Synuclein Overview
    1.1 Product Overview and Scope of Alpha Synuclein
    1.2 Classification of Alpha Synuclein by Product Category
        1.2.1 United States Alpha Synuclein Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Alpha Synuclein Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 AV-1950R
        1.2.4 AV-1947D
        1.2.5 BAN-0805
        1.2.6 BIIB-054
        1.2.7 DPC-003
        1.2.8 Others
    1.3 United States Alpha Synuclein Market by Application/End Users
        1.3.1 United States Alpha Synuclein Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Multiple System Atrophy
        1.3.3 Neurodegenerateive Disease
        1.3.4 Lewy Body Dementia
        1.3.5 Others
    1.4 United States Alpha Synuclein Market by Region
        1.4.1 United States Alpha Synuclein Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Alpha Synuclein Status and Prospect (2012-2022)
        1.4.3 Southwest Alpha Synuclein Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Alpha Synuclein Status and Prospect (2012-2022)
        1.4.5 New England Alpha Synuclein Status and Prospect (2012-2022)
        1.4.6 The South Alpha Synuclein Status and Prospect (2012-2022)
        1.4.7 The Midwest Alpha Synuclein Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Alpha Synuclein (2012-2022)
        1.5.1 United States Alpha Synuclein Sales and Growth Rate (2012-2022)
        1.5.2 United States Alpha Synuclein Revenue and Growth Rate (2012-2022)

2 United States Alpha Synuclein Market Competition by Players/Suppliers
    2.1 United States Alpha Synuclein Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Alpha Synuclein Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Alpha Synuclein Average Price by Players/Suppliers (2012-2017)
    2.4 United States Alpha Synuclein Market Competitive Situation and Trends
        2.4.1 United States Alpha Synuclein Market Concentration Rate
        2.4.2 United States Alpha Synuclein Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Alpha Synuclein Manufacturing Base Distribution, Sales Area, Product Type

3 United States Alpha Synuclein Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Alpha Synuclein Sales and Market Share by Region (2012-2017)
    3.2 United States Alpha Synuclein Revenue and Market Share by Region (2012-2017)
    3.3 United States Alpha Synuclein Price by Region (2012-2017)

4 United States Alpha Synuclein Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Alpha Synuclein Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Alpha Synuclein Revenue and Market Share by Type (2012-2017)
    4.3 United States Alpha Synuclein Price by Type (2012-2017)
    4.4 United States Alpha Synuclein Sales Growth Rate by Type (2012-2017)

5 United States Alpha Synuclein Sales (Volume) by Application (2012-2017)
    5.1 United States Alpha Synuclein Sales and Market Share by Application (2012-2017)
    5.2 United States Alpha Synuclein Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Alpha Synuclein Players/Suppliers Profiles and Sales Data
    6.1 AC Immune SA
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Alpha Synuclein Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AC Immune SA Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 AFFiRiS AG
        6.2.2 Alpha Synuclein Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 AFFiRiS AG Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 BioArctic AB
        6.3.2 Alpha Synuclein Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 BioArctic AB Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Biogen Inc
        6.4.2 Alpha Synuclein Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Biogen Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Evotec AG
        6.5.2 Alpha Synuclein Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Evotec AG Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Genmab A/S
        6.6.2 Alpha Synuclein Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Genmab A/S Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 H. Lundbeck A/S
        6.7.2 Alpha Synuclein Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 H. Lundbeck A/S Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 ICB International Inc
        6.8.2 Alpha Synuclein Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 ICB International Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 MedImmune LLC
        6.9.2 Alpha Synuclein Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 MedImmune LLC Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Neuropore Therapies Inc
        6.10.2 Alpha Synuclein Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Neuropore Therapies Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 nLife Therapeutics SL
    6.12 Prothena Corp Plc
    6.13 QR Pharma Inc
    6.14 reMYND NV

7 Alpha Synuclein Manufacturing Cost Analysis
    7.1 Alpha Synuclein Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Alpha Synuclein

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Alpha Synuclein Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Alpha Synuclein Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Alpha Synuclein Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Alpha Synuclein Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Alpha Synuclein Sales Volume Forecast by Type (2017-2022)
    11.3 United States Alpha Synuclein Sales Volume Forecast by Application (2017-2022)
    11.4 United States Alpha Synuclein Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer